TY - JOUR AU - Rovaris, M. AU - Confavreux, C. AU - Furlan, R. AU - Kappos, L. AU - Comi, G. AU - Filippi, M. PY - 2006 DA - 2006// TI - Secondary progressive multiple sclerosis: current knowledge and future challenges JO - Lancet Neurol VL - 5 UR - https://doi.org/10.1016/S1474-4422(06)70410-0 DO - 10.1016/S1474-4422(06)70410-0 ID - Rovaris2006 ER - TY - JOUR AU - Trapp, B. D. AU - Nave, K. A. PY - 2008 DA - 2008// TI - Multiple sclerosis: an immune or neurodegenerative disorder? JO - Annu Rev Neurosci VL - 31 UR - https://doi.org/10.1146/annurev.neuro.30.051606.094313 DO - 10.1146/annurev.neuro.30.051606.094313 ID - Trapp2008 ER - TY - JOUR AU - Filippi, M. AU - Rocca, M. A. PY - 2005 DA - 2005// TI - MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system JO - J Neurol VL - 252 UR - https://doi.org/10.1007/s00415-005-5004-5 DO - 10.1007/s00415-005-5004-5 ID - Filippi2005 ER - TY - JOUR AU - Bø, L. AU - Vedeler, C. A. AU - Nyland, H. AU - Trapp, B. D. AU - Mørk, S. J. PY - 2003 DA - 2003// TI - Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration JO - Mult Scler VL - 9 UR - https://doi.org/10.1191/1352458503ms917oa DO - 10.1191/1352458503ms917oa ID - Bø2003 ER - TY - JOUR AU - Weiner, H. L. PY - 2009 DA - 2009// TI - The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? JO - Ann Neurol VL - 65 UR - https://doi.org/10.1002/ana.21640 DO - 10.1002/ana.21640 ID - Weiner2009 ER - TY - JOUR AU - Frischer, J. M. AU - Bramow, S. AU - Dal-Bianco, A. AU - Lucchinetti, C. F. AU - Rauschka, H. AU - Schmidbauer, M. AU - Laursen, H. AU - Sorensen, P. S. AU - Lassmann, H. PY - 2009 DA - 2009// TI - The relation between inflammation and neurodegeneration in multiple sclerosis brains JO - Brain VL - 132 UR - https://doi.org/10.1093/brain/awp070 DO - 10.1093/brain/awp070 ID - Frischer2009 ER - TY - STD TI - Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS. Lancet. 1998; 352(9139):1491–1497. ID - ref7 ER - TY - JOUR AU - Panitch, H. AU - Miller, A. AU - Paty, D. AU - Weinshenker, B. PY - 2004 DA - 2004// TI - MS NASGoIb-biSP: Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study JO - Neurology VL - 63 UR - https://doi.org/10.1212/01.WNL.0000146958.77317.3E DO - 10.1212/01.WNL.0000146958.77317.3E ID - Panitch2004 ER - TY - JOUR AU - Mantia, L. L. AU - Vacchi, L. AU - Rovaris, M. AU - Pietrantonj, C. AU - Ebers, G. AU - Fredrikson, S. AU - Filippini, G. PY - 2013 DA - 2013// TI - Interferon beta for secondary progressive multiple sclerosis: a systematic review JO - J Neurol Neurosurg Psychiatry VL - 84 UR - https://doi.org/10.1136/jnnp-2012-303291 DO - 10.1136/jnnp-2012-303291 ID - Mantia2013 ER - TY - JOUR AU - Croze, E. AU - Yamaguchi, K. D. AU - Knappertz, V. AU - Reder, A. T. AU - Salamon, H. PY - 2013 DA - 2013// TI - Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis JO - Pharmacogenomics J VL - 13 UR - https://doi.org/10.1038/tpj.2012.27 DO - 10.1038/tpj.2012.27 ID - Croze2013 ER - TY - JOUR AU - Wandinger, K. P. AU - Stürzebecher, C. S. AU - Bielekova, B. AU - Detore, G. AU - Rosenwald, A. AU - Staudt, L. M. AU - McFarland, H. F. AU - Martin, R. PY - 2001 DA - 2001// TI - Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes JO - Ann Neurol VL - 50 UR - https://doi.org/10.1002/ana.1096 DO - 10.1002/ana.1096 ID - Wandinger2001 ER - TY - JOUR AU - Singh, M. K. AU - Scott, T. F. AU - LaFramboise, W. A. AU - Hu, F. Z. AU - Post, J. C. AU - Ehrlich, G. D. PY - 2007 DA - 2007// TI - Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy JO - J Neurol Sci VL - 258 UR - https://doi.org/10.1016/j.jns.2007.02.034 DO - 10.1016/j.jns.2007.02.034 ID - Singh2007 ER - TY - JOUR AU - Baarsen, L. G. AU - Vosslamber, S. AU - Tijssen, M. AU - Baggen, J. M. AU - Voort, L. F. AU - Killestein, J. AU - Pouw Kraan, T. C. AU - Polman, C. H. AU - Verweij, C. L. PY - 2008 DA - 2008// TI - Pharmacogenomics of interferon-beta therapy in multiple sclerosis: baseline IFN signature determines pharmacological differences between patients JO - PLoS One VL - 3 UR - https://doi.org/10.1371/journal.pone.0001927 DO - 10.1371/journal.pone.0001927 ID - Baarsen2008 ER - TY - JOUR AU - Yamaguchi, K. D. AU - Ruderman, D. L. AU - Croze, E. AU - Wagner, T. C. AU - Velichko, S. AU - Reder, A. T. AU - Salamon, H. PY - 2008 DA - 2008// TI - IFN-beta-regulated genes show abnormal expression in therapy-naïve relapsing-remitting MS mononuclear cells: gene expression analysis employing all reported protein-protein interactions JO - J Neuroimmunol VL - 195 UR - https://doi.org/10.1016/j.jneuroim.2007.12.007 DO - 10.1016/j.jneuroim.2007.12.007 ID - Yamaguchi2008 ER - TY - JOUR AU - Dhib-Jalbut, S. AU - Marks, S. PY - 2010 DA - 2010// TI - Interferon-beta mechanisms of action in multiple sclerosis JO - Neurology VL - 74 UR - https://doi.org/10.1212/WNL.0b013e3181c97d99 DO - 10.1212/WNL.0b013e3181c97d99 ID - Dhib-Jalbut2010 ER - TY - JOUR AU - Sturzebecher, S. AU - Wandinger, K. P. AU - Rosenwald, A. AU - Sathyamoorthy, M. AU - Tzou, A. AU - Mattar, P. AU - Frank, J. A. AU - Staudt, L. AU - Martin, R. AU - McFarland, H. F. PY - 2003 DA - 2003// TI - Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis JO - Brain VL - 126 UR - https://doi.org/10.1093/brain/awg147 DO - 10.1093/brain/awg147 ID - Sturzebecher2003 ER - TY - JOUR AU - Verweij, C. L. AU - Vosslamber, S. PY - 2013 DA - 2013// TI - Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy JO - Discov Med VL - 15 ID - Verweij2013 ER - TY - JOUR AU - Comabella, M. AU - Lunemann, J. D. AU - Rio, J. AU - Sanchez, A. AU - Lopez, C. AU - Julia, E. AU - Fernandez, M. AU - Nonell, L. AU - Camina-Tato, M. AU - Deisenhammer, F. PY - 2009 DA - 2009// TI - A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis JO - Brain VL - 132 UR - https://doi.org/10.1093/brain/awp228 DO - 10.1093/brain/awp228 ID - Comabella2009 ER - TY - JOUR AU - Bustamante, M. F. AU - Nurtdinov, R. N. AU - Rio, J. AU - Montalban, X. AU - Comabella, M. PY - 2013 DA - 2013// TI - Baseline gene expression signatures in monocytes from multiple sclerosis patients treated with interferon-beta JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0060994 DO - 10.1371/journal.pone.0060994 ID - Bustamante2013 ER - TY - JOUR AU - Ratzer, R. AU - Søndergaard, H. B. AU - Christensen, J. R. AU - Börnsen, L. AU - Borup, R. AU - Sørensen, P. S. AU - Sellebjerg, F. PY - 2013 DA - 2013// TI - Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis JO - Mult Scler VL - 19 UR - https://doi.org/10.1177/1352458513500553 DO - 10.1177/1352458513500553 ID - Ratzer2013 ER - TY - JOUR AU - Polman, C. H. AU - Reingold, S. C. AU - Banwell, B. AU - Clanet, M. AU - Cohen, J. A. AU - Filippi, M. AU - Fujihara, K. AU - Havrdova, E. AU - Hutchinson, M. AU - Kappos, L. PY - 2011 DA - 2011// TI - Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria JO - Ann Neurol VL - 69 UR - https://doi.org/10.1002/ana.22366 DO - 10.1002/ana.22366 ID - Polman2011 ER - TY - BOOK AU - Team, R. C. PY - 2013 DA - 2013// TI - R: A language and environment for statistical computing PB - R foundation for Statistical Computing CY - Vienna, Austria ID - Team2013 ER - TY - JOUR AU - Piccolo, S. R. AU - Sun, Y. AU - Campbell, J. D. AU - Lenburg, M. E. AU - Bild, A. H. AU - Johnson, W. E. PY - 2012 DA - 2012// TI - A single-sample microarray normalization method to facilitate personalized-medicine workflows JO - Genomics VL - 100 UR - https://doi.org/10.1016/j.ygeno.2012.08.003 DO - 10.1016/j.ygeno.2012.08.003 ID - Piccolo2012 ER - TY - JOUR AU - Leek, J. T. AU - Johnson, W. E. AU - Parker, H. S. AU - Jaffe, A. E. AU - Storey, J. D. PY - 2012 DA - 2012// TI - The sva package for removing batch effects and other unwanted variation in high-throughput experiments JO - Bioinformatics VL - 28 UR - https://doi.org/10.1093/bioinformatics/bts034 DO - 10.1093/bioinformatics/bts034 ID - Leek2012 ER - TY - JOUR AU - Bertolotto, A. AU - Sala, A. AU - Caldano, M. AU - Capobianco, M. AU - Malucchi, S. AU - Marnetto, F. AU - Gilli, F. PY - 2007 DA - 2007// TI - Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta JO - J Immunol Methods VL - 321 UR - https://doi.org/10.1016/j.jim.2006.12.012 DO - 10.1016/j.jim.2006.12.012 ID - Bertolotto2007 ER - TY - JOUR AU - Hecker, M. AU - Hartmann, C. AU - Kandulski, O. AU - Paap, B. K. AU - Koczan, D. AU - Thiesen, H. J. AU - Zettl, U. K. PY - 2013 DA - 2013// TI - Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood JO - Mol Neurobiol VL - 48 UR - https://doi.org/10.1007/s12035-013-8463-1 DO - 10.1007/s12035-013-8463-1 ID - Hecker2013 ER - TY - JOUR AU - Paap, B. K. AU - Hundeshagen, A. AU - Hecker, M. AU - Zettl, U. K. PY - 2012 DA - 2012// TI - An inventory of short term and long term changes in gene expression under interferon beta treatment of relapsing remitting MS patients JO - Curr Pharm Des VL - 18 UR - https://doi.org/10.2174/138161212802502215 DO - 10.2174/138161212802502215 ID - Paap2012 ER - TY - JOUR AU - Voort, L. F. AU - Visser, A. AU - Knol, D. L. AU - Oudejans, C. B. AU - Polman, C. H. AU - Killestein, J. PY - 2009 DA - 2009// TI - Lack of interferon-beta bioactivity is associated with the occurrence of relapses in multiple sclerosis JO - Eur J Neurol VL - 16 UR - https://doi.org/10.1111/j.1468-1331.2009.02649.x DO - 10.1111/j.1468-1331.2009.02649.x ID - Voort2009 ER - TY - JOUR AU - Byun, E. AU - Caillier, S. J. AU - Montalban, X. AU - Villoslada, P. AU - Fernández, O. AU - Brassat, D. AU - Comabella, M. AU - Wang, J. AU - Barcellos, L. F. AU - Baranzini, S. E. PY - 2008 DA - 2008// TI - Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis JO - Arch Neurol VL - 65 UR - https://doi.org/10.1001/archneurol.2008.47 DO - 10.1001/archneurol.2008.47 ID - Byun2008 ER - TY - JOUR AU - Comabella, M. AU - Craig, D. W. AU - Morcillo-Suárez, C. AU - Río, J. AU - Navarro, A. AU - Fernández, M. AU - Martin, R. AU - Montalban, X. PY - 2009 DA - 2009// TI - Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis JO - Arch Neurol VL - 66 UR - https://doi.org/10.1001/archneurol.2009.150 DO - 10.1001/archneurol.2009.150 ID - Comabella2009 ER - TY - JOUR AU - Mahurkar, S. AU - Suppiah, V. AU - O'Doherty, C. PY - 2014 DA - 2014// TI - Pharmacogenomics of interferon beta and glatiramer acetate response: a review of the literature JO - Autoimmun Rev VL - 13 UR - https://doi.org/10.1016/j.autrev.2013.10.012 DO - 10.1016/j.autrev.2013.10.012 ID - Mahurkar2014 ER -